All In Biotech

Drug Trial Radar · NCT07824674

The Effect of Additive On-Demand Sildenafil vs. Dextrose Candy on Maximum Exercise Capacity in Pulmonary Arterial Hypertension

The Effect of Additive On-Demand Sildenafil vs. Dextrose Candy on Maximum Exercise Capacity in Pulmonary Arterial Hypertension: A Randomized, Cross-Over Trial.

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Oct 26, 2026

Primary completion

Apr 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Silvia UlrichAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical study is to investigate whether the additional intake of sildenafil 20mg on top of standard medical treatment results in a benefit on maximum exercise workload (Wmax) in patients with pulmonary arterial hypertension (PAH).

Conditions

  • Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

Interventions

  • DextroseDrug

    Administration of Dextrose Candy by mouth as a tablet.

  • Sildenafil 20mgDrug

    Administration of Sildenafil 20mg by mouth as a tablet.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum workload (Wmax)Time frame: Within 1 - 90 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Hospital of Zurich, Department of Pulmonology

    Zurich, Canton of Zurich, Switzerland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.